Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 2022-07, Vol.97 (7), p.E276-E280 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E280 |
|---|---|
| container_issue | 7 |
| container_start_page | E276 |
| container_title | American journal of hematology |
| container_volume | 97 |
| creator | Mohan, Meera Becnel, Melody Renee Shah, Urvi A. Dong, Huaying Gundarlapalli, Sravani Peterson, Timothy Orozco, Jennifer S. Horowitz, Sandra Chhabra, Saurabh Dhakal, Binod Thanendrarajan, Sharmilan Radhakrishnan, Sabarinath Venniyil Al Hadidi, Samer Tan, Carlyn Mailankody, Sham Hultcrantz, Malin Korde, Neha Hassoun, Hani Lesokhin, Alexander M. Thomas, Sheeba K. Patel, Krina K. Manasanch, Elisabet E. Weber, Donna M. Szabo, Aniko Kaufman, Gregory P. Lee, Hans C. Zangari, Maurizio Rhee, Frits Usmani, Saad Z. D'Souza, Anita Orlowski, Robert Z. Schinke, Carolina |
| description | |
| doi_str_mv | 10.1002/ajh.26580 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10476149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2675611939</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3590-377ca5c04dc69746ec1b0935880f3e88ab3859f639b9d4ea2531a83ab2ddb9443</originalsourceid><addsrcrecordid>eNp1kc1u1DAURiMEokNhwQsgS2xgMa0dJ47NphpNgYIqsYG15Tg3U48cO9gOkF0foc_Ik-BpSgVIrK5_jo_t-xXFc4JPCMblqdpfnZSs5vhBsSJYsDVndfmwWGHKSB5jcVQ8iXGPMSEVx4-LI1pXTUlYsyputtY4o5VF0Pe56hn5HkX4OoHTxu3Q9pxylFTYQTpMB--8tt7lA8ol0_rOQETGoQBWjRG6POiD0smHGQ2TTWa0gIYZrB_UG7RZ1n5e3xgXk0lTMrcu-DFCMPlKeFo86pWN8OyuHhdf3r39vL1YX356_2G7uVxrWgu8pk2jVa1x1WkmmoqBJi0WtOYc9xQ4Vy3ltegZFa3oKlBlTYniVLVl17WiquhxcbZ4x6kdoNPgUlBWjsEMKszSKyP_3nHmSu78N0lw1TBSiWx4dWcIPrcrJjmYqMFa5cBPUeZEGBGNYDijL_9B934K-eMHqskYEfQgfL1QOvgYcx_vX0OwPAQtc9DyNujMvvjz-ffk72QzcLoA342F-f8mufl4sSh_ATvUtow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2675611939</pqid></control><display><type>article</type><title>Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Mohan, Meera ; Becnel, Melody Renee ; Shah, Urvi A. ; Dong, Huaying ; Gundarlapalli, Sravani ; Peterson, Timothy ; Orozco, Jennifer S. ; Horowitz, Sandra ; Chhabra, Saurabh ; Dhakal, Binod ; Thanendrarajan, Sharmilan ; Radhakrishnan, Sabarinath Venniyil ; Al Hadidi, Samer ; Tan, Carlyn ; Mailankody, Sham ; Hultcrantz, Malin ; Korde, Neha ; Hassoun, Hani ; Lesokhin, Alexander M. ; Thomas, Sheeba K. ; Patel, Krina K. ; Manasanch, Elisabet E. ; Weber, Donna M. ; Szabo, Aniko ; Kaufman, Gregory P. ; Lee, Hans C. ; Zangari, Maurizio ; Rhee, Frits ; Usmani, Saad Z. ; D'Souza, Anita ; Orlowski, Robert Z. ; Schinke, Carolina</creator><creatorcontrib>Mohan, Meera ; Becnel, Melody Renee ; Shah, Urvi A. ; Dong, Huaying ; Gundarlapalli, Sravani ; Peterson, Timothy ; Orozco, Jennifer S. ; Horowitz, Sandra ; Chhabra, Saurabh ; Dhakal, Binod ; Thanendrarajan, Sharmilan ; Radhakrishnan, Sabarinath Venniyil ; Al Hadidi, Samer ; Tan, Carlyn ; Mailankody, Sham ; Hultcrantz, Malin ; Korde, Neha ; Hassoun, Hani ; Lesokhin, Alexander M. ; Thomas, Sheeba K. ; Patel, Krina K. ; Manasanch, Elisabet E. ; Weber, Donna M. ; Szabo, Aniko ; Kaufman, Gregory P. ; Lee, Hans C. ; Zangari, Maurizio ; Rhee, Frits ; Usmani, Saad Z. ; D'Souza, Anita ; Orlowski, Robert Z. ; Schinke, Carolina</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.26580</identifier><identifier>PMID: 35472167</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>ADP-ribosyl Cyclase 1 ; Antibodies, Monoclonal - therapeutic use ; Antineoplastic Agents, Immunological - therapeutic use ; CD38 antigen ; Hematology ; Humans ; Monoclonal antibodies ; Multiple myeloma ; Multiple Myeloma - drug therapy ; Multiple Myeloma - genetics ; Treatment Outcome</subject><ispartof>American journal of hematology, 2022-07, Vol.97 (7), p.E276-E280</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3590-377ca5c04dc69746ec1b0935880f3e88ab3859f639b9d4ea2531a83ab2ddb9443</citedby><cites>FETCH-LOGICAL-c3590-377ca5c04dc69746ec1b0935880f3e88ab3859f639b9d4ea2531a83ab2ddb9443</cites><orcidid>0000-0001-8545-3292 ; 0000-0002-5538-4318 ; 0000-0003-2593-411X ; 0000-0002-1092-5643 ; 0000-0002-0857-176X ; 0000-0002-6913-6526 ; 0000-0001-9117-8696 ; 0000-0001-9959-1282 ; 0000-0001-7922-2594 ; 0000-0002-1720-3854 ; 0000-0003-4297-8042 ; 0000-0002-2699-1741 ; 0000-0002-4377-9742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.26580$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.26580$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27903,27904,45553,45554,46387,46811</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35472167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Becnel, Melody Renee</creatorcontrib><creatorcontrib>Shah, Urvi A.</creatorcontrib><creatorcontrib>Dong, Huaying</creatorcontrib><creatorcontrib>Gundarlapalli, Sravani</creatorcontrib><creatorcontrib>Peterson, Timothy</creatorcontrib><creatorcontrib>Orozco, Jennifer S.</creatorcontrib><creatorcontrib>Horowitz, Sandra</creatorcontrib><creatorcontrib>Chhabra, Saurabh</creatorcontrib><creatorcontrib>Dhakal, Binod</creatorcontrib><creatorcontrib>Thanendrarajan, Sharmilan</creatorcontrib><creatorcontrib>Radhakrishnan, Sabarinath Venniyil</creatorcontrib><creatorcontrib>Al Hadidi, Samer</creatorcontrib><creatorcontrib>Tan, Carlyn</creatorcontrib><creatorcontrib>Mailankody, Sham</creatorcontrib><creatorcontrib>Hultcrantz, Malin</creatorcontrib><creatorcontrib>Korde, Neha</creatorcontrib><creatorcontrib>Hassoun, Hani</creatorcontrib><creatorcontrib>Lesokhin, Alexander M.</creatorcontrib><creatorcontrib>Thomas, Sheeba K.</creatorcontrib><creatorcontrib>Patel, Krina K.</creatorcontrib><creatorcontrib>Manasanch, Elisabet E.</creatorcontrib><creatorcontrib>Weber, Donna M.</creatorcontrib><creatorcontrib>Szabo, Aniko</creatorcontrib><creatorcontrib>Kaufman, Gregory P.</creatorcontrib><creatorcontrib>Lee, Hans C.</creatorcontrib><creatorcontrib>Zangari, Maurizio</creatorcontrib><creatorcontrib>Rhee, Frits</creatorcontrib><creatorcontrib>Usmani, Saad Z.</creatorcontrib><creatorcontrib>D'Souza, Anita</creatorcontrib><creatorcontrib>Orlowski, Robert Z.</creatorcontrib><creatorcontrib>Schinke, Carolina</creatorcontrib><title>Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>ADP-ribosyl Cyclase 1</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antineoplastic Agents, Immunological - therapeutic use</subject><subject>CD38 antigen</subject><subject>Hematology</subject><subject>Humans</subject><subject>Monoclonal antibodies</subject><subject>Multiple myeloma</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Multiple Myeloma - genetics</subject><subject>Treatment Outcome</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURiMEokNhwQsgS2xgMa0dJ47NphpNgYIqsYG15Tg3U48cO9gOkF0foc_Ik-BpSgVIrK5_jo_t-xXFc4JPCMblqdpfnZSs5vhBsSJYsDVndfmwWGHKSB5jcVQ8iXGPMSEVx4-LI1pXTUlYsyputtY4o5VF0Pe56hn5HkX4OoHTxu3Q9pxylFTYQTpMB--8tt7lA8ol0_rOQETGoQBWjRG6POiD0smHGQ2TTWa0gIYZrB_UG7RZ1n5e3xgXk0lTMrcu-DFCMPlKeFo86pWN8OyuHhdf3r39vL1YX356_2G7uVxrWgu8pk2jVa1x1WkmmoqBJi0WtOYc9xQ4Vy3ltegZFa3oKlBlTYniVLVl17WiquhxcbZ4x6kdoNPgUlBWjsEMKszSKyP_3nHmSu78N0lw1TBSiWx4dWcIPrcrJjmYqMFa5cBPUeZEGBGNYDijL_9B934K-eMHqskYEfQgfL1QOvgYcx_vX0OwPAQtc9DyNujMvvjz-ffk72QzcLoA342F-f8mufl4sSh_ATvUtow</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Mohan, Meera</creator><creator>Becnel, Melody Renee</creator><creator>Shah, Urvi A.</creator><creator>Dong, Huaying</creator><creator>Gundarlapalli, Sravani</creator><creator>Peterson, Timothy</creator><creator>Orozco, Jennifer S.</creator><creator>Horowitz, Sandra</creator><creator>Chhabra, Saurabh</creator><creator>Dhakal, Binod</creator><creator>Thanendrarajan, Sharmilan</creator><creator>Radhakrishnan, Sabarinath Venniyil</creator><creator>Al Hadidi, Samer</creator><creator>Tan, Carlyn</creator><creator>Mailankody, Sham</creator><creator>Hultcrantz, Malin</creator><creator>Korde, Neha</creator><creator>Hassoun, Hani</creator><creator>Lesokhin, Alexander M.</creator><creator>Thomas, Sheeba K.</creator><creator>Patel, Krina K.</creator><creator>Manasanch, Elisabet E.</creator><creator>Weber, Donna M.</creator><creator>Szabo, Aniko</creator><creator>Kaufman, Gregory P.</creator><creator>Lee, Hans C.</creator><creator>Zangari, Maurizio</creator><creator>Rhee, Frits</creator><creator>Usmani, Saad Z.</creator><creator>D'Souza, Anita</creator><creator>Orlowski, Robert Z.</creator><creator>Schinke, Carolina</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8545-3292</orcidid><orcidid>https://orcid.org/0000-0002-5538-4318</orcidid><orcidid>https://orcid.org/0000-0003-2593-411X</orcidid><orcidid>https://orcid.org/0000-0002-1092-5643</orcidid><orcidid>https://orcid.org/0000-0002-0857-176X</orcidid><orcidid>https://orcid.org/0000-0002-6913-6526</orcidid><orcidid>https://orcid.org/0000-0001-9117-8696</orcidid><orcidid>https://orcid.org/0000-0001-9959-1282</orcidid><orcidid>https://orcid.org/0000-0001-7922-2594</orcidid><orcidid>https://orcid.org/0000-0002-1720-3854</orcidid><orcidid>https://orcid.org/0000-0003-4297-8042</orcidid><orcidid>https://orcid.org/0000-0002-2699-1741</orcidid><orcidid>https://orcid.org/0000-0002-4377-9742</orcidid></search><sort><creationdate>202207</creationdate><title>Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience</title><author>Mohan, Meera ; Becnel, Melody Renee ; Shah, Urvi A. ; Dong, Huaying ; Gundarlapalli, Sravani ; Peterson, Timothy ; Orozco, Jennifer S. ; Horowitz, Sandra ; Chhabra, Saurabh ; Dhakal, Binod ; Thanendrarajan, Sharmilan ; Radhakrishnan, Sabarinath Venniyil ; Al Hadidi, Samer ; Tan, Carlyn ; Mailankody, Sham ; Hultcrantz, Malin ; Korde, Neha ; Hassoun, Hani ; Lesokhin, Alexander M. ; Thomas, Sheeba K. ; Patel, Krina K. ; Manasanch, Elisabet E. ; Weber, Donna M. ; Szabo, Aniko ; Kaufman, Gregory P. ; Lee, Hans C. ; Zangari, Maurizio ; Rhee, Frits ; Usmani, Saad Z. ; D'Souza, Anita ; Orlowski, Robert Z. ; Schinke, Carolina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3590-377ca5c04dc69746ec1b0935880f3e88ab3859f639b9d4ea2531a83ab2ddb9443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ADP-ribosyl Cyclase 1</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antineoplastic Agents, Immunological - therapeutic use</topic><topic>CD38 antigen</topic><topic>Hematology</topic><topic>Humans</topic><topic>Monoclonal antibodies</topic><topic>Multiple myeloma</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Multiple Myeloma - genetics</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Becnel, Melody Renee</creatorcontrib><creatorcontrib>Shah, Urvi A.</creatorcontrib><creatorcontrib>Dong, Huaying</creatorcontrib><creatorcontrib>Gundarlapalli, Sravani</creatorcontrib><creatorcontrib>Peterson, Timothy</creatorcontrib><creatorcontrib>Orozco, Jennifer S.</creatorcontrib><creatorcontrib>Horowitz, Sandra</creatorcontrib><creatorcontrib>Chhabra, Saurabh</creatorcontrib><creatorcontrib>Dhakal, Binod</creatorcontrib><creatorcontrib>Thanendrarajan, Sharmilan</creatorcontrib><creatorcontrib>Radhakrishnan, Sabarinath Venniyil</creatorcontrib><creatorcontrib>Al Hadidi, Samer</creatorcontrib><creatorcontrib>Tan, Carlyn</creatorcontrib><creatorcontrib>Mailankody, Sham</creatorcontrib><creatorcontrib>Hultcrantz, Malin</creatorcontrib><creatorcontrib>Korde, Neha</creatorcontrib><creatorcontrib>Hassoun, Hani</creatorcontrib><creatorcontrib>Lesokhin, Alexander M.</creatorcontrib><creatorcontrib>Thomas, Sheeba K.</creatorcontrib><creatorcontrib>Patel, Krina K.</creatorcontrib><creatorcontrib>Manasanch, Elisabet E.</creatorcontrib><creatorcontrib>Weber, Donna M.</creatorcontrib><creatorcontrib>Szabo, Aniko</creatorcontrib><creatorcontrib>Kaufman, Gregory P.</creatorcontrib><creatorcontrib>Lee, Hans C.</creatorcontrib><creatorcontrib>Zangari, Maurizio</creatorcontrib><creatorcontrib>Rhee, Frits</creatorcontrib><creatorcontrib>Usmani, Saad Z.</creatorcontrib><creatorcontrib>D'Souza, Anita</creatorcontrib><creatorcontrib>Orlowski, Robert Z.</creatorcontrib><creatorcontrib>Schinke, Carolina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohan, Meera</au><au>Becnel, Melody Renee</au><au>Shah, Urvi A.</au><au>Dong, Huaying</au><au>Gundarlapalli, Sravani</au><au>Peterson, Timothy</au><au>Orozco, Jennifer S.</au><au>Horowitz, Sandra</au><au>Chhabra, Saurabh</au><au>Dhakal, Binod</au><au>Thanendrarajan, Sharmilan</au><au>Radhakrishnan, Sabarinath Venniyil</au><au>Al Hadidi, Samer</au><au>Tan, Carlyn</au><au>Mailankody, Sham</au><au>Hultcrantz, Malin</au><au>Korde, Neha</au><au>Hassoun, Hani</au><au>Lesokhin, Alexander M.</au><au>Thomas, Sheeba K.</au><au>Patel, Krina K.</au><au>Manasanch, Elisabet E.</au><au>Weber, Donna M.</au><au>Szabo, Aniko</au><au>Kaufman, Gregory P.</au><au>Lee, Hans C.</au><au>Zangari, Maurizio</au><au>Rhee, Frits</au><au>Usmani, Saad Z.</au><au>D'Souza, Anita</au><au>Orlowski, Robert Z.</au><au>Schinke, Carolina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2022-07</date><risdate>2022</risdate><volume>97</volume><issue>7</issue><spage>E276</spage><epage>E280</epage><pages>E276-E280</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>35472167</pmid><doi>10.1002/ajh.26580</doi><tpages>55</tpages><orcidid>https://orcid.org/0000-0001-8545-3292</orcidid><orcidid>https://orcid.org/0000-0002-5538-4318</orcidid><orcidid>https://orcid.org/0000-0003-2593-411X</orcidid><orcidid>https://orcid.org/0000-0002-1092-5643</orcidid><orcidid>https://orcid.org/0000-0002-0857-176X</orcidid><orcidid>https://orcid.org/0000-0002-6913-6526</orcidid><orcidid>https://orcid.org/0000-0001-9117-8696</orcidid><orcidid>https://orcid.org/0000-0001-9959-1282</orcidid><orcidid>https://orcid.org/0000-0001-7922-2594</orcidid><orcidid>https://orcid.org/0000-0002-1720-3854</orcidid><orcidid>https://orcid.org/0000-0003-4297-8042</orcidid><orcidid>https://orcid.org/0000-0002-2699-1741</orcidid><orcidid>https://orcid.org/0000-0002-4377-9742</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 2022-07, Vol.97 (7), p.E276-E280 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10476149 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
| subjects | ADP-ribosyl Cyclase 1 Antibodies, Monoclonal - therapeutic use Antineoplastic Agents, Immunological - therapeutic use CD38 antigen Hematology Humans Monoclonal antibodies Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - genetics Treatment Outcome |
| title | Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T19%3A47%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20efficacy%20of%20sequencing%20CD38%20targeting%20monoclonal%20antibodies%20in%20relapsed%20refractory%20multiple%20myeloma:%20A%20multi%E2%80%90institutional%20experience&rft.jtitle=American%20journal%20of%20hematology&rft.au=Mohan,%20Meera&rft.date=2022-07&rft.volume=97&rft.issue=7&rft.spage=E276&rft.epage=E280&rft.pages=E276-E280&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.26580&rft_dat=%3Cproquest_pubme%3E2675611939%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2675611939&rft_id=info:pmid/35472167&rfr_iscdi=true |